These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Metabolism of hallucinogens in brain and other tissues. Ho BT Psychopharmacol Bull; 1975 Jul; 11(3):61-2. PubMed ID: 1153673 [No Abstract] [Full Text] [Related]
8. [Demonstration of the formation of psychotropic amphetamine derivatives from nutmeg components]. Braun U; Kalbhen DA Dtsch Med Wochenschr; 1972 Oct; 97(42):1614-5. PubMed ID: 5077548 [No Abstract] [Full Text] [Related]
9. Studies with a tritium-labeled psychotomimetic agent. ABOOD LG; RINALDI F Psychopharmacologia; 1959 Nov; 1():117-23. PubMed ID: 13791503 [No Abstract] [Full Text] [Related]
10. [Biochemical, pharmacological and clinical studies with opiates, cannabinoles, stimulants and hallucinogens]. Matussek N Offentl Gesundheitswes; 1971 Sep; 33(9):534-40. PubMed ID: 4258151 [No Abstract] [Full Text] [Related]
11. Metabolic fate of methoxamine and n-isopropylmethoxamine. Klutch A; Bordun M J Med Chem; 1967 Sep; 10(5):861-3. PubMed ID: 6048492 [No Abstract] [Full Text] [Related]
12. Metabolism of a beta blocking drug, oxprenolol. Garteiz DA J Pharmacol Exp Ther; 1971 Nov; 179(2):354-8. PubMed ID: 4399963 [No Abstract] [Full Text] [Related]
13. The disposition of butriptyline in rats, dogs and man. Cameron BD; Chasscaud LF; Lewis JD; Taylor T Arzneimittelforschung; 1974 Jan; 24(1):93-6. PubMed ID: 4406119 [No Abstract] [Full Text] [Related]
14. [Study of resorption, distribution, and elimination of Halidor using labelled Halidor]. Blaskó K; Nagy J Acta Pharm Hung; 1968 Jun; 38(2):91-7. PubMed ID: 5749328 [No Abstract] [Full Text] [Related]
15. Studies on the CNS-availability of amphetamine from amphetaminil. Honecker H Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):121-8. PubMed ID: 1165132 [TBL] [Abstract][Full Text] [Related]
16. [Assay of lauryloxypropylamine in biologic media. Pharmacokinetic study after intravenous administration in rabbits]. Guggenbuhl P; De Burlet G; Andermann G Ann Pharm Fr; 1985; 43(3):281-90. PubMed ID: 4083693 [No Abstract] [Full Text] [Related]
17. A model of harmine metabolism in the rat. Slotkin TA; DiStefano V J Pharmacol Exp Ther; 1970 Sep; 174(3):456-62. PubMed ID: 5456178 [No Abstract] [Full Text] [Related]
18. [Role of the liver in the biotransformation of carcinogens and anticarcinogens. I. Effect of cyclophosphamide on hepatic acetylcholinesterase and P-450 cytochrome in rats]. Martínez Zedillo G; Magdaleno VM Prensa Med Mex; 1972; 37(3):124-31. PubMed ID: 4626456 [No Abstract] [Full Text] [Related]
19. Distribution, metabolism and excretion of bufotenine in the rat with preliminary studies of its O-methyl derivative. Sanders E; Bush MT J Pharmacol Exp Ther; 1967 Nov; 158(2):340-52. PubMed ID: 6065154 [No Abstract] [Full Text] [Related]
20. [On the pharmacology of a series of diphenylaminopropane derivatives]. Schmidt D; Hüller H; Amon I; Peters R Pharmazie; 1973 Oct; 28(10):677-80. PubMed ID: 4783556 [No Abstract] [Full Text] [Related] [Next] [New Search]